Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer-Reference-Cited by-同舟云学术

Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer

Published:2004-08 Issue:2 Volume:240 Page:306-312
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Schoppmann Sebastian F.,Bayer Guenther,Aumayr Klaus,Taucher Susanne,Geleff Silvana,Rudas Margaretha,Kubista Ernst,Hausmaninger Hubert,Samonigg Hellmut,Gnant Michael,Jakesz Raimund,Horvat Reinhard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference38 articles.

1. Tumor-related prognostic factors for breast cancer.;Donegan;CA Cancer J Clin,1997

2. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update.;Fisher;Cancer,1983

3. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma.;Weidner;N Engl J Med,1991

4. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.;Weidner;J Natl Cancer Inst,1992

5. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies [Review].;Schoppmann;Oncol Rep,2002

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual pure intralymphatic carcinoma component only (lymphovascular tumor emboli without invasive carcinoma) after neoadjuvant chemotherapy is associated with poor outcome: Not pathologic complete response;Human Pathology;2024-02

2. Clinical Characteristics and Management of Triple-Negative Breast Cancer (TNBC) in Jordan: A Retrospective Analysis;Cureus;2024-01-27

3. Evaluation of Lymphangiogenesis in Breast Carcinomas Using D2-40 Immunostain;Indian Journal of Gynecologic Oncology;2024-01-06

4. Development and structure of the lymphoid system;Clinical Immuno-Oncology;2024

5. Receptor tyrosine kinases: biological functions and anticancer targeted therapy;MedComm;2023-12